- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 20-03-2026: Press Release
20-03-2026 | 09:31 am
20-03-2026 | 09:31 am
NATCO Pharma launches generic Semaglutide injection (multi-dose vials) in India, priced from INR 1,290/month. This makes it the most affordable GLP-1 therapy, significantly boosting accessibility and patient compliance. Pen device launch expected in April.
No comments yet. Be the first to comment!